terazosin
Generic: terazosin hydrochloride
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
terazosin
Generic Name
terazosin hydrochloride
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
terazosin hydrochloride 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-510
Product ID
71610-510_b23a32b3-7e6b-4b58-be96-303ac3ef069a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075317
Listing Expiration
2026-12-31
Marketing Start
2020-03-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610510
Hyphenated Format
71610-510
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
terazosin (source: ndc)
Generic Name
terazosin hydrochloride (source: ndc)
Application Number
ANDA075317 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (71610-510-30)
- 60 CAPSULE in 1 BOTTLE (71610-510-53)
- 90 CAPSULE in 1 BOTTLE (71610-510-60)
- 120 CAPSULE in 1 BOTTLE (71610-510-70)
- 180 CAPSULE in 1 BOTTLE (71610-510-80)
- 270 CAPSULE in 1 BOTTLE (71610-510-92)
- 360 CAPSULE in 1 BOTTLE (71610-510-94)
Packages (7)
71610-510-30
30 CAPSULE in 1 BOTTLE (71610-510-30)
71610-510-53
60 CAPSULE in 1 BOTTLE (71610-510-53)
71610-510-60
90 CAPSULE in 1 BOTTLE (71610-510-60)
71610-510-70
120 CAPSULE in 1 BOTTLE (71610-510-70)
71610-510-80
180 CAPSULE in 1 BOTTLE (71610-510-80)
71610-510-92
270 CAPSULE in 1 BOTTLE (71610-510-92)
71610-510-94
360 CAPSULE in 1 BOTTLE (71610-510-94)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b23a32b3-7e6b-4b58-be96-303ac3ef069a", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217", "313219"], "spl_set_id": ["81d5422c-ff57-4f6d-927c-5de4dd7e1169"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71610-510-30)", "package_ndc": "71610-510-30", "marketing_start_date": "20201229"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71610-510-53)", "package_ndc": "71610-510-53", "marketing_start_date": "20201229"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-510-60)", "package_ndc": "71610-510-60", "marketing_start_date": "20201229"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71610-510-70)", "package_ndc": "71610-510-70", "marketing_start_date": "20201229"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-510-80)", "package_ndc": "71610-510-80", "marketing_start_date": "20201229"}, {"sample": false, "description": "270 CAPSULE in 1 BOTTLE (71610-510-92)", "package_ndc": "71610-510-92", "marketing_start_date": "20201229"}, {"sample": false, "description": "360 CAPSULE in 1 BOTTLE (71610-510-94)", "package_ndc": "71610-510-94", "marketing_start_date": "20201229"}], "brand_name": "Terazosin", "product_id": "71610-510_b23a32b3-7e6b-4b58-be96-303ac3ef069a", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-510", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20200330", "listing_expiration_date": "20261231"}